Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.

ABSTRACT:

SUBMITTER: Alicandro G 

PROVIDER: S-EPMC8847104 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature